Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week

1. Grail shares surged to a record high amid cancer screening optimism. 2. Larry Ellison discussed leveraging AI for cancer vaccine development. 3. Grail's stock broke out of a cup and handle pattern indicating bullish momentum. 4. Upside target projected at $46 based on technical analysis. 5. Key support levels to watch are around $23 and $20.